Sponsor/Principal Investigator: John Halpern, M.D. Location: McLean Hospital, Harvard Medical School, Belmont, MA (USA) Dr. Halpern is the Sponsor/Investigator. In his FDA IND application, he cross-referenced …
Psychiatric News Volume 40, Number 2, p. 46 January 21, 2005 http://pn.psychiatryonline.org/cgi/content/full/40/2/46-a?eaf FDA Approves Study of Ecstasy In Some Terminally Ill Patients Eve Bender Researchers …
the Harvard Crimson January 5, 2005 http://www.thecrimson.com/article.aspx?ref=505257 HMS will Give Ecstasy to Terminal Cancer Patients by [MAPS comments and corrections, in brackets, by Ilsa Jerome] More …
The Washington Post Monday, December 27, 2004 http://www.washingtonpost.com/wp-dyn/articles/A27716-2004Dec26.html "Ecstasy" Use Studied to Ease Fear in Terminally Ill by Rick Weiss For some, the diagnosis …
